TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
FLGT

Fulgent Genetics Inc

Healthcare · Diagnostics & Research

21.70$ -0.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement FLGT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+649.3% +90.9% +2.5% +14.0% +52.3% +1,196.5% +135.4% -37.6% -53.3% -2.0% +13.8%
+441.6% +32.6% +27.2% +25.0% +31.9% +536.6% +140.0% +17.0% -26.7% -4.6% +8.8%
+1,217.8% +156.4% -11.9% +4.8% +72.7% +1,701.8% +134.1% -52.8% -71.5% +2.6% +22.1%
+750.5% -19.7% +18.7% +31.0% +18.1% +77.1% +109.1% +19.4% +43.3% +17.8% +10.4%
+951.3% +90.6% +11.4% +7.9% +15.8% +137.2% +233.4% +118.9% -19.9% -1.0% +32.4%
+614.6% +11.7% +27.7% +15.8% +19.9% +121.5% +149.9% +80.5% +59.2% -39.6% +22.5%
-470.0% -64.0% +71.1% -209.5%
-100.0% -83.7% +1,653.1% -83.7% -51.8% -65.2% -55.9%
+71,216.4% -64.2% +76.4% -194.6%
+1.1% -72.4% -183.5% +168,579.1% +141.0% -75.9% -97.3% -805.0%
+58,454.6% -51.3% +37.4% -217.0%
-180.0% +17,358.0% -63.8% +105.3% -167.7%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?